» Articles » PMID: 33996043

Vigilance to Misleading Information is Required to Avoid Delayed Diagnosis: Case Series of Acral Melanomas

Abstract

Introduction: Melanoma is considered a rare cancer among Asians with a wide range of mucocutaneous manifestations. Failure to recognize a lesion as melanoma at first presentation might delay surgery aimed at complete resection. Acral melanoma has been related with the highest rate of misdiagnosis (~30%) causing further delayed diagnosis. Reliability of patient' history taking in melanoma has not yet been systematically reported.

Presented Cases: Two patients visited our oncology clinic with pigmented lesions in their soles. A 66-year-old man disclosed it appeared since a year ago after accidently hitting a stone while farming. Physical examination showed a black-brown irregular 100 × 80 mm lesion covering the distal third of the right sole with ulceration in the central lesion. The second patient was a geriatric woman with a black-purple 25 × 27 mm lesion with slight protrusion and ulceration in the central, irregular border, and partial hyperkeratosis. She explained the lesion emerged two years ago after she accidently stepped on a nail. Both patients were then diagnosed with acral melanomas and were treated with wide-excision, closure with skin grafting, and inguinal dissection.

Discussion: Both patients reported history of traumas in lesions later confirmed as acral melanomas. Although history taking can provide up to 80% of the information for accurate diagnosis, in ambivalent cases, careful anamnesis, clinical examination, and biopsy are required to confirm diagnosis of acral melanoma. Early disease identification to establish definitive diagnosis of cancer is generally associated with better clinical outcomes. In suspected cases, vigilance toward misleading information in history taking is required.

Citing Articles

BRAF and NRAS Mutations and the Association with Prognosis of Acral Lentiginous and Nodular Melanomas in Indonesia.

Anwar S, Ferronika P, Cahyono R, Sugandhi W, Pradana G Asian Pac J Cancer Prev. 2024; 25(10):3525-3531.

PMID: 39471018 PMC: 11711374. DOI: 10.31557/APJCP.2024.25.10.3525.

References
1.
Teramoto Y, Keim U, Gesierich A, Schuler G, Fiedler E, Tuting T . Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients. Br J Dermatol. 2017; 178(2):443-451. DOI: 10.1111/bjd.15803. View

2.
Bristow I, Acland K . Acral lentiginous melanoma of the foot and ankle: A case series and review of the literature. J Foot Ankle Res. 2008; 1(1):11. PMC: 2553782. DOI: 10.1186/1757-1146-1-11. View

3.
Tod B, Schneider J, Bowcock A, Visser W, Kotze M . The tumor genetics of acral melanoma: What should a dermatologist know?. JAAD Int. 2021; 1(2):135-147. PMC: 8329760. DOI: 10.1016/j.jdin.2020.07.004. View

4.
Sartore L, Papanikolaou G, Biancari F, Mazzoleni F . Prognostic factors of cutaneous melanoma in relation to metastasis at the sentinel lymph node: a case-controlled study. Int J Surg. 2008; 6(3):205-9. DOI: 10.1016/j.ijsu.2008.03.003. View

5.
Metzger S, Ellwanger U, Stroebel W, Schiebel U, Rassner G, Fierlbeck G . Extent and consequences of physician delay in the diagnosis of acral melanoma. Melanoma Res. 1998; 8(2):181-6. DOI: 10.1097/00008390-199804000-00014. View